Matinas Biopharma Holdings, Inc. (Matinas BioPharma or the Company) — (NYSE AMER:MTNB), a clinical-stage biopharmaceutical
This post first appeared on Global Banking And Finance Review Magazine – Fin, please read the originial post: here
Matinas BioPharma Announces Proposed Public Offering of Common Stock
This post first appeared on Global Banking And Finance Review Magazine – Fin, please read the originial post: here
